Phase one clinical trials of hyperthermia using radiofrequency capacitive heating device and magnetic cationic liposome in prostate cancer resistant to standard treatment
Not Applicable
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000021187
- Lead Sponsor
- agoya City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included the following: the patients who received radical prostatectomy; Case with metal reacting to the magnetic field in the body (Pacemaker, implant denture, iron clip bolt); patients with pleural effusion, ascitic fluid, the pericardial effusion which need urgent treatment; patients with active infection; patients with the multiple primary cancer with less than five years in disease-free interval; patients who communication is not possible; patients who is not suitable for local anesthesia; patients who has circulatory; during anticoagulation; patients of the diabetes mellitus inadequate control; the case that a chief physician judged to be unsuitable for subject of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequencies of adverse events grade 3 or more of CTCAE v4.0 Adverse events are evaluated at just after, 12 hours later, 24 hours later, one week later and on month later of injection of magnetite
- Secondary Outcome Measures
Name Time Method